Entities / Company
Avidity.
American biotech company
- Reports this week
- 0
- Active events
- 0
- Connections
- 25
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
One to three months ago
-
Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Some support5 reports
-
Novartis acquired Regulus Therapeutics in April, while also reportedly weighing a potential deal with Avidity Biosciences.Well supported10 reports1 development inside
-
Avidity Biosciences, a San Diego-based company, announced a partnership with Eli Lilly and is also facing acquisition interest from Novartis.Well supported7 reports1 development inside
Gone quiet
No new reports in 90+ days-
Cantor Fitzgerald and Leerink Partners initiated analyst coverage on Avidity Biosciences on August 10, 2026.Some support3 reports
-
Avidity listed its stock on the Nasdaq stock exchange on June 17, 2026.Some support1 report
-
Avidity Biosciences, based in San Diego, has aligned with the FDA regarding its product approval pathways. Mike Maclean serves as the company's CFO.Some support1 report1 development inside
-
Avidity Biosciences, based in San Diego, has aligned with the FDA regarding its product approval pathways. Mike Maclean serves as the company's CFO.Some support1 report
-
Avidity is headquartered in San Diego, CA.Some support1 report
No events began in the chosen period. Widen it, or reset.
Explainers that pass through Avidity
Avidity is a step on the way to someone elseAround Avidity this week
News at the entities that move Avidity most-
Novartis StructuralBristol-Myers Squibb paused clinical trials following clinical setbacks reported by Novartis.Moves Avidity
-
FDA StructuralFDA approved combination clearances for Elanco's Experior use on June 27, 2025.Moves Avidity
-
Nasdaq OperationalNasdaq experienced its worst month in over a year as of November 11, 2026.Moves Avidity
-
Cantor Fitzgerald Mentioned togetherCantor Fitzgerald, Citigroup, and MarketBeat issued rating updates and price targets for Rigel Pharmaceuticals, Inc.Moves Avidity
-
Leerink partners Mentioned togetherLeerink Partners began coverage on Shattuck Labs shares, and TD Cowen subsequently raised the shares to a strong-buy rating.Moves Avidity
-
San Diego Shared contextVervent, a San Diego-based financial technology company, is expanding its services into vacation ownership.Moves Avidity
Connections
The 7 strongest of 25, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Novartis Structural
Novartis acquired Avidity Biosciences for $12 billion and continues to integrate its technology into its drug development pipeline.
-
Steve Hughes Structural
Steve Hughes holds the position of chief medical officer at Avidity.
-
FDA Structural
Avidity's drug development and market access are structurally dependent on regulatory approval and designation from the FDA.
-
Nasdaq Operational
Avidity is listed on the Nasdaq stock exchange.
-
Cantor Fitzgerald Mentioned together
Cantor Fitzgerald initiated market coverage of Avidity Biosciences as of August 2026.
-
Leerink partners Mentioned together
Leerink Partners initiated financial coverage on Avidity Biosciences.
-
San Diego Shared context
Avidity is headquartered and operates within San Diego, CA.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
1 eventJune 2026
6 events- Novartis acquired Regulus Therapeutics in April, while also reportedly weighing a potential deal with Avidity Biosciences.
- Avidity Biosciences, a San Diego-based company, announced a partnership with Eli Lilly and is also facing acquisition interest from Novartis.
- Avidity listed its stock on the Nasdaq stock exchange on June 17, 2026.
- Avidity Biosciences, based in San Diego, has aligned with the FDA regarding its product approval pathways. Mike Maclean serves as the company's CFO.
- Avidity Biosciences, based in San Diego, has aligned with the FDA regarding its product approval pathways. Mike Maclean serves as the company's CFO.
- Avidity is headquartered in San Diego, CA.